Koh, M. J., Lagos, G., Santopietro, A., Desai, B., Oldenburg, N. B. E., Golijanin, D., Khaleel, S. S., Yoo, D., Hyams, E. S., El-Deiry, W. S., Mega, A. E., Carneiro, B. A. (2026). Association of SPOP mutation with survival outcomes following
                    <sup>177</sup>
                    Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17055